Related Experiment Video
Updated: Aug 30, 2026

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
Published on: July 16, 2014
Small molecules targeting the NMDA receptor complex as drugs for neuropathic pain
Rosa Planells-Cases1, Enrique Pérez-Payá, Angel Messeguer
1Instituto de Biología Molecular y Celular, Universidad Miguel Hernández, Alicante, Spain.
Abstract:
Pain is a complex disease that usually remains poorly treated or undertreated, especially the neuropathic pain caused by injury to the peripheral or central nervous system. Antagonists of the NMDA receptor complex have emerged as potential drugs for pain management. A strong case is being raised for non-competitive or uncompetitive antagonists with low-to-moderate affinity and fast on/offset kinetics as drugs with good therapeutic profiles, because of their reduced side effects.
Related Concept Videos
Analgesia and Pain Management
Antiepileptic Drugs: Glutamate Antagonists
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Neurochemical Transmission: Sites of Drug Action
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
